IMARC Group's report titled “Anti-Infectives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global anti-infectives market size reached US$ 130.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 157.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.46% during 2023-2028.

Anti-infectives represent medicines that act against infections, either by killing the infectious agent outright or inhibiting the spread. They consist of antibiotics, antifungals, antivirals, antimalarials, anthelmintics, antiprotozoals, etc. These anti-infectives are generally administered through oral, parenteral, or topical routes. They help to treat minor infectious diseases, including pneumonia and tuberculosis, and give vital immuno-suppressive treatments, such as chemotherapy, to people suffering from cancer. Anti-infectives even prove highly effective during cesarian section, joint replacement, and other routine procedures and surgeries that are associated with a high risk of severe infection. Consequently, they find extensive applications in hospitals, clinics, and other healthcare establishments across the globe.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anti-infectives-market/requestsample

Anti-Infectives Market Trends and Drivers:

The elevating incidences of various infectious diseases across countries are primarily driving the anti-infectives market. Additionally, the introduction of novel drugs formulated using several strategies, which include natural products, quorum sensing inhibitors, gallium-based drugs, cyclodextrin inhibitors, biofilm disruptors, light-based antimicrobials, etc., and the increasing innovation in drug discovery processes, including stem cells and organ-on-chip or OOC technologies, to improve drug trial processes are acting as significant growth-inducing factors. Besides this, the rising number of new anti-infective drugs being approved by the regulatory authorities and the growing product adoption, owing to the sudden outbreak of the COVID-19 pandemic and the induced infections, such as aspergillosis, invasive candidiasis, mucormycosis, etc., are also positively influencing the global market. Moreover, the launch of favorable policies by government bodies aimed at supporting the development of new and innovative drugs and the inflating investments in healthcare infrastructure improvements are anticipated to catalyze the anti-infectives market in the coming years.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Type:

  • Antibacterial
  • Antifungal
  • Antiviral

Breakup by Route of Administration:

  • Topical
  • Oral
  • Intravenous (IV) 
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Speciality Pharmacies
  • Online Stores
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbott Laboratories
  • Cipla Health Ltd. (Cipla Limited)
  • Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson
  • Lupin Limited
  • Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal